Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for MDD and Cannabis Disorder in Youth
NCT00149643Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Sep 2004
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), cannabis use disorder (CUD), sponsored by University of Pittsburgh. Started Sep 2004; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00149643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149643.